| [YIA] The influence of skin barrier disruption and melanin content on the formation of DNA lesions and radicals in ex vivo human skin induced by 233 nm far-UVC irradiation from … L Busch, J Schleusener, DFZ Díaz, M Kröger, SB Lohan, P Zwicker, ... Free Radical Biology and Medicine 189, 30-31, 2022 | | 2022 |
| * Free University of Berlin, Berlin, Germany;** Athenion GmbH, Berlin, Germany GB Romero, W Brysch, CM Keck, RH Müller Nanoencapsulation Technologies for the Food and Nutraceutical Industries, 165, 2017 | | 2017 |
| 3.9 Natural Compounds M Rincon-Fontan, D Knoth, AB Moldes, JM Cruz, CM Keck Conference Book, 151, 2018 | | 2018 |
| A new concept for the treatment of atopic dermatitis: Silver–nanolipid complex (sNLC) CM Keck, P Anantaworasakul, M Patel, S Okonogi, KK Singh, D Roessner, ... International journal of pharmaceutics 462 (1-2), 44-51, 2014 | 38 | 2014 |
| Acknowledgement to Reviewers of Pharmaceutics in S Ahadian, M Anraku, MN Antipina, K Ariga, I Bácskay, AK Bansal, ... | | 2017 |
| Active-loaded particulate materials for topical administration FH Monsuur, HH Hoefer, C Keck US Patent App. 15/508,393, 2017 | 6 | 2017 |
| Activity-Guided Characterization of COX-2 Inhibitory Compounds in Waltheria indica L. Extracts M Termer, C Carola, A Salazar, CM Keck, J Hemberger, J von Hagen Molecules 26 (23), 7240, 2021 | 6 | 2021 |
| Advanced Skin Antisepsis: Application of UVA-Cleavable Hydroxyethyl Starch Nanocapsules for Improved Eradication of Hair Follicle-Associated Microorganisms L Busch, AM Hanuschik, Y Avlasevich, K Darm, EF Hochheiser, C Kohler, ... Pharmaceutics 15 (2), 609, 2023 | 1 | 2023 |
| Amorphous cyclosporin A nanoparticles for enhanced dermal bioavailability GB Romero, A Arntjen, CM Keck, RH Müller International journal of pharmaceutics 498 (1-2), 217-224, 2016 | 72 | 2016 |
| Amorphous Drugs in Porous Materials–Stability, Solubility & Tablet Performance RH Müller, CM Keck, Q Wei | | |
| Anti-Aging-Strategies: Innovative Concepts for Developing Anti-Aging Dermo-Cosmetics CM Keck hautnah 17, 52-62, 2018 | 1 | 2018 |
| Antioxidant Capacity of Tailor-made Quercetin Nanocrystals with KRL Test R Chen, M Prost, L Greiner, RH Müller, CM Keck 40th CRS Annual Meeting & Exposition, Honolulu, 2013 | 1 | 2013 |
| Application of 233 nm far-UVC LEDs for eradication of MRSA and MSSA and risk assessment on skin models P Zwicker, J Schleusener, SB Lohan, L Busch, C Sicher, S Einfeldt, ... Scientific Reports 12 (1), 2587, 2022 | 37 | 2022 |
| Application of Biofluorescent Particle Counters for Real-Time Bioburden Control in Aseptic Cleanroom Manufacturing D Behrens, J Schaefer, CM Keck, FE Runkel Applied Sciences 12 (16), 8108, 2022 | 2 | 2022 |
| Are lipid nanoparticles really superior? A holistic proof of concept study S Wiemann, CM Keck Drug Delivery and Translational Research, 1-12, 2021 | 21 | 2021 |
| ART nanocrystals-a novel simple method for the production of nanocrystals in industrial scale R Chen, Ö Kumanova, CM Keck, RH Müller | | |
| ARTcrystal® process for industrial nanocrystal production—optimization of the ART MICCRA pre-milling step P Scholz, A Arntjen, RH Müller, CM Keck International journal of pharmaceutics 465 (1-2), 388-395, 2014 | 28 | 2014 |
| ARTcrystals®–Nanocrystal Production & Physical Long-Term Stability RH Müller, R Chen, CM Keck | | |
| Assessing the dermal penetration efficacy of chemical compounds with the ex-vivo porcine ear model CM Keck, A Abdelkader, O Pelikh, S Wiemann, V Kaushik, D Specht, ... Pharmaceutics 14 (3), 678, 2022 | 23 | 2022 |
| Assessing the oxidative state of the skin by combining classical tape stripping with ORAC assay RM Alnemari, J Brüßler, CM Keck Pharmaceuticals 15 (5), 520, 2022 | 2 | 2022 |
